This compound is a sulfonyl-substituted pyrrolopyrazine carbamate used as a pharmaceutical intermediate. Its structure features a pyrrolo[2,3-b]pyrazine core with a 4-methylphenylsulfonyl group and an ethyl carbamate moiety, conferring moderate lipophilicity and a hydrogen-bond donor site.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1869118-24-0
1,1-Dimethylethyl N-(5-((4-methylphenyl)sulfonyl)-5H-pyrrolo(2,3-b)pyrazin-2-yl)carbamate
Pharmaceutical intermediate for upadacitinib synthesis
2-(2-cyanophenyl)acetic acid
Pharmaceutical intermediate
2-Methyl-3-nitropyridine
pharmaceutical intermediate
(S)-4-(3-bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline
pharmaceutical intermediate
Mc-Val-Ala-PAB
pharmaceutical intermediate
2-Bromo-5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazine
Pharmaceutical intermediate for kinase inhibitors
ethyl N-[5-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyrazin-2-yl]carbamate
NROPCWMCOWTXAZ-UHFFFAOYSA-N
CCOC(=O)NC1=CN=C2C(=N1)C=CN2S(=O)(=O)C3=CC=C(C=C3)C
—